Spok Holdings sells the paging and communications software that hospitals use to route clinical alerts, staff pages and secure messages between devices, with its Spok Care Connect platform the main product for hospital customers. The core advantage is installed base: hospitals that have built alerting workflows around Spok tend to stay, and the business still earns a 60.4% gross margin and 19.9% operating margin. Revenue is shrinking, though, down 1.9%, so the thesis rests on whether the margin structure can hold while the top line stabilizes. The stock trades at 18.8 times trailing earnings but 10.2 times forward earnings, a gap that implies analysts expect earnings to rise even as sales fall. Return on equity of 8.4% is modest, and the score of 48 out of 100 along with no index membership suggests this is a small, under-followed name that needs a closer look at cash flow and customer retention before it earns a place in the book.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 18 Oct 2026, 15:06 CEST | Rating | Undervalued | first publication | $10.61 |
| 15 Oct 2026, 00:00 CEST | ACCE price target | $10.80 | first publication | $10.83 |
| 14 Oct 2026, 00:00 CEST | Fair value | $12.33 | $10.98 | $10.74 |
| 29 Sept 2026, 00:00 CEST | Fair value | $10.98 | $11.10 | $10.46 |
| 15 Sept 2026, 00:00 CEST | Fair value | $11.10 | $11.26 | $10.65 |
| 10 Sept 2026, 00:00 CEST | Fair value | $11.26 | $11.40 | $10.64 |
| 30 Aug 2026, 00:00 CEST | Fair value | $11.40 | $11.87 | $10.65 |
| 27 Aug 2026, 00:00 CEST | Fair value | $11.87 | $11.43 | $10.45 |
| 25 Aug 2026, 00:00 CEST | Fair value | $11.43 | $11.87 | $10.43 |
| 22 Aug 2026, 00:00 CEST | Fair value | $11.87 | $11.74 | $10.48 |
Answered from Spok Holdings Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| SPOK Spok Holdings Inc. Common Stock | $10.30 | $12 | 17% below | 18.8x | 8.4% | 75 | 48 |
| ASCN.SW Ascom Holding AG | CHF 5.72 | CHF 7 | 20% below | 11.0x | 25.7% | 78 | 73 |
| SY So-Young International Inc. American Depository Shares | $2.11 | - | - | - | -15.0% | 43 | 48 |
| AMWL American Well Corporation Class A Common Stock | $13.57 | - | - | - | -29.1% | 43 | 42 |
| CARA.ST Carasent AB (publ) | kr 27.00 | kr 15 | 84% above | 45.8x | 4.8% | 66 | 58 |
| OPRX OptimizeRx Corporation Common Stock | $9.15 | $9 | 3% below | 38.1x | 3.7% | 54 | 51 |
| SUS.ST Surgical Science Sweden AB (publ) | kr 57.20 | kr 56 | 2% above | 31.4x | 2.1% | 70 | 63 |
Where SPOK ranks against its sector peers on each metric.